New Blood Test Detects Early Lung Damage in Cancer Patients on Targeted Therapy

A revolutionary blood test developed by researchers at Hadassah Medical Center detects early lung damage in cancer patients receiving antibody-drug conjugates (ADCs). This non-invasive method offers a timely alternative to traditional imaging, improving patient outcomes and safety by allowing for early intervention in cases of interstitial lung disease (ILD).